What does APOTHEEK KAREN LIEVENS do?

APOTHEEK KAREN LIEVENS is a pharmacy in Lokeren. Public Limited, started on 8 July 1974, 1 establishment.

What is the address of APOTHEEK KAREN LIEVENS?

The registered office of APOTHEEK KAREN LIEVENS is located at Stationsstraat 28, 9160 Lokeren.

Is APOTHEEK KAREN LIEVENS still active?

Yes. According to the CBE (30 October 2026) APOTHEEK KAREN LIEVENS is active, legal situation “Normale toestand”, started on 8 July 1974.

Is APOTHEEK KAREN LIEVENS registered on Peppol?

Yes, APOTHEEK KAREN LIEVENS is registered on the Peppol network with ID 0208:0414457541.

What is the enterprise number of APOTHEEK KAREN LIEVENS?

The enterprise number of APOTHEEK KAREN LIEVENS is BE0414457541.

When was APOTHEEK KAREN LIEVENS founded?

APOTHEEK KAREN LIEVENS was founded on 8 July 1974.

Who are the directors of APOTHEEK KAREN LIEVENS?

According to the 2025 annual accounts, the directors of APOTHEEK KAREN LIEVENS are: Paul Lievens, Liliane De Bruycker, KL Holding BVBA.

Is APOTHEEK KAREN LIEVENS a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 8 July 1974; 5 annual accounts filed, latest fiscal year 2025; 3 directors known from the annual account.

How much profit did APOTHEEK KAREN LIEVENS make in 2025?

APOTHEEK KAREN LIEVENS posted a profit after taxes of € 103,346 in financial year 2025.

What is the revenue of APOTHEEK KAREN LIEVENS?

As a small company, APOTHEEK KAREN LIEVENS is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 354,058.

How much does an employee at APOTHEEK KAREN LIEVENS earn?

The average wage cost per full-time employee at APOTHEEK KAREN LIEVENS was € 72,800 in 2025: staff costs of € 182,055 for 2.5 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does APOTHEEK KAREN LIEVENS have?

According to the 2025 annual accounts, APOTHEEK KAREN LIEVENS has 2.5 full-time equivalents (FTE).

APOTHEEK KAREN LIEVENS (Public Limited) - Lokeren

Dossier APOTHEEK KAREN LIEVENS, printed on 30 October 2026 from databakkes.be/en/0414457541/apotheek-karen-lievens. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

APOTHEEK KAREN LIEVENS from Lokeren, company number BE0414457541, closed financial year 2025 with a result of € 103,346 after tax. For that financial year APOTHEEK KAREN LIEVENS recorded a gross margin of € 354,058 and equity of € 1.6 million. Compared with financial year 2024, the result moved from € -69,829 to € 103,346. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 22, 2026.

What it is worth Growing

€ 1.6 million

▲ 95% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 103,346

▲ still € 69,829 loss in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 279,105

▲ 40% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 880,180.

People and assets in 2025

Full-time equivalents

2.5

▼ 0.1 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 182,055

€ 72,800 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 34,034

▼ 25% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 4 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 109,153

▼ 19% vs 2024

€ 25,787 is repaid this year. At this pace the long-term loan is gone in ≈ 4 years.

Owed to suppliers

€ 303,413

▲ 16% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Wages and social charges

€ 21,035

▼ 15% vs 2024

Wages, holiday pay and social contributions still to pay. No outstanding taxes.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 180,417 Gross margin 2022: € 180,417 First fiscal year in the series	€ 168,657 Gross margin 2023: € 168,657 ▼ 7% vs 2022 (€ 180,417) Unfavourable step	€ 180,442 Gross margin 2024: € 180,442 ▲ 7% vs 2023 (€ 168,657) Favourable step	€ 354,058 Gross margin 2025: € 354,058 ▲ 96% vs 2024 (€ 180,442) Favourable step	▲ 96%
Profit after taxes	€ -24,379 Profit after taxes 2022: € -24,379 First fiscal year in the series	€ -43,743 Profit after taxes 2023: € -43,743 ▼ € 19,365 vs 2022 (€ -24,379) Unfavourable step	€ -69,829 Profit after taxes 2024: € -69,829 ▼ € 26,085 vs 2023 (€ -43,743) Unfavourable step	€ 103,346 Profit after taxes 2025: € 103,346 ▲ € 173,175 vs 2024 (€ -69,829) Favourable step	▲ € 173,175
Equity	€ 952,407 Equity 2022: € 952,407 First fiscal year in the series	€ 908,663 Equity 2023: € 908,663 ▼ 5% vs 2022 (€ 952,407) Unfavourable step	€ 838,834 Equity 2024: € 838,834 ▼ 8% vs 2023 (€ 908,663) Unfavourable step	€ 1,632,180 Equity 2025: € 1,632,180 ▲ 95% vs 2024 (€ 838,834) Favourable step	▲ 95%
Total debts	€ 268,584 Total debts 2022: € 268,584 First fiscal year in the series	€ 310,208 Total debts 2023: € 310,208 ▲ 15% vs 2022 (€ 268,584) Unfavourable step	€ 420,791 Total debts 2024: € 420,791 ▲ 36% vs 2023 (€ 310,208) Unfavourable step	€ 433,602 Total debts 2025: € 433,602 ▲ 3% vs 2024 (€ 420,791) Unfavourable step	▲ 3%
Cash	€ 262,752 Cash 2022: € 262,752 First fiscal year in the series	€ 280,558 Cash 2023: € 280,558 ▲ 7% vs 2022 (€ 262,752) Favourable step	€ 199,218 Cash 2024: € 199,218 ▼ 29% vs 2023 (€ 280,558) Unfavourable step	€ 279,105 Cash 2025: € 279,105 ▲ 40% vs 2024 (€ 199,218) Favourable step	▲ 40%
Land & buildings	€ 431,908 Land & buildings 2022: € 431,908 First fiscal year in the series	€ 406,452 Land & buildings 2023: € 406,452 ▼ 6% vs 2022 (€ 431,908) Unchanged	€ 382,780 Land & buildings 2024: € 382,780 ▼ 6% vs 2023 (€ 406,452) Unchanged	€ 1,062,390 Land & buildings 2025: € 1,062,390 ▲ 178% vs 2024 (€ 382,780) Unchanged	▲ 178%
Retained profit	€ 890,407 Retained profit 2022: € 890,407 First fiscal year in the series	€ 846,663 Retained profit 2023: € 846,663 ▼ 5% vs 2022 (€ 890,407) Unfavourable step	€ 776,834 Retained profit 2024: € 776,834 ▼ 8% vs 2023 (€ 846,663) Unfavourable step	€ 880,180 Retained profit 2025: € 880,180 ▲ 13% vs 2024 (€ 776,834) Favourable step	▲ 13%
Bank debt	€ 0 Bank debt 2022: € 0 First fiscal year in the series	€ 0 Bank debt 2023: € 0 Unchanged (€ 0) Unchanged	€ 134,000 Bank debt 2024: € 134,000 Unchanged (€ 0) Unfavourable step	€ 109,153 Bank debt 2025: € 109,153 ▼ 19% vs 2024 (€ 134,000) Favourable step	▼ 19%
Balance sheet total	€ 1,220,991 Balance sheet total 2022: € 1,220,991 First fiscal year in the series	€ 1,218,871 Balance sheet total 2023: € 1,218,871 Unchanged (€ 1,220,991) Unchanged	€ 1,259,626 Balance sheet total 2024: € 1,259,626 ▲ 3% vs 2023 (€ 1,218,871) Unchanged	€ 2,065,782 Balance sheet total 2025: € 2,065,782 ▲ 64% vs 2024 (€ 1,259,626) Unchanged	▲ 64%
Employees (FTE)	2.6 Employees (FTE) 2022: 2.6 First fiscal year in the series	2.6 Employees (FTE) 2023: 2.6 Unchanged (2.6) Unchanged	2.6 Employees (FTE) 2024: 2.6 Unchanged (2.6) Unchanged	2.5 Employees (FTE) 2025: 2.5 ▼ 0.1 vs 2024 (2.6) Unchanged	▼ 0.1

Key figures of APOTHEEK KAREN LIEVENS, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to APOTHEEK KAREN LIEVENS?

What happened at APOTHEEK KAREN LIEVENS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 22, 2026 New annual accounts for financial year 2025: profit of € 103,346. Source: NBB ↗
Sep 1, 1974 New establishment in Lokeren. KBO
Jul 8, 1974 Start of the company according to the CBE. KBO

In short

From € 24,379 loss in 2022 to € 103,346 profit in 2025.

Best year ever: 2025, with € 103,346 profit.

On average € 141,600 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

KL Holding 99%

The stake of KL Holding comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

APOTHEEK KAREN LIEVENS

Behind APOTHEEK KAREN LIEVENS are Paul Lievens, Liliane De Bruycker and KL Holding BVBA. The shares are held by KL Holding (99%).

Directors

According to the 2025 annual accounts

Paul Lievens

Director

Also active at: GB 338

Liliane De Bruycker

Director

Also active at: GB 338

KL Holding BVBA

Managing director · represented by Karen Lievens

Shareholders

KL Holding

99%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Stationsstraat 28

9160 Lokeren

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

ROVANI

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0414.457.541

VAT number

BE 0414.457.541

Registered office

Stationsstraat 28, 9160 Lokeren

Names & denominations

APOTHEEK KAREN LIEVENS

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Normale toestand

Start date

8 July 1974

Peppol

Active · Active since 6 Jan 2026

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

View on CBE Public ↗ Annual accounts (NBB) ↗

APOTHEEK KAREN LIEVENS

Financials

What happened to APOTHEEK KAREN LIEVENS?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions